Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy-Reference-Cited by-同舟云学术

Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy

Published:2023 Issue: Volume:21 Page:100574
ISSN:2589-9864
Container-title:Epilepsy & Behavior Reports
language:en
Short-container-title:Epilepsy & Behavior Reports

Author:

Driessen J.T.,Wammes–van der Heijden E.A.,Verschuure P.,Fasen K.C.F.M.,Teunissen M.W.A.,Majoie H.J.M.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference25 articles.

1. How long does it take for epilepsy to become intractable? A prospective investigation;Berg;Ann Neurol,2006

2. Side Effects of Antiepileptics— A Review;Walia;Pain Practice,2004

3. UBC. Vimpat. Published 2017. Accessed November 10, 2021. https://www.ucb.com/stories-media/Press-Releases/article/UCB-s-anti-epileptic-drug-VIMPAT-lacosamide-receives-EU-approval-for-paediatric-use.

4. Vimpat | European Medicines Agency. Accessed May 2, 2022. https://www.ema.europa.eu/en/medicines/human/EPAR/vimpat.

5. CHMP. Vimpat, INN-lacosamide. Accessed January 22, 2022. www.ema.europa.eu/contact.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-seizure Medications: Challenges and Opportunities;CNS & Neurological Disorders - Drug Targets;2024-09

2. Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study;CNS Neuroscience & Therapeutics;2024-08

3. Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study;Frontiers in Pharmacology;2023-08-09

4. Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system;Seizure: European Journal of Epilepsy;2023-08